Satavaptan Dose-Ranging Study in Hyponatraemic Patients With Cirrhotic Ascites
NCT00501722
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
110
Enrollment
INDUSTRY
Sponsor class
Conditions
Ascites
Liver Cirrhosis
Interventions
DRUG:
satavaptan (SR121463B)
Sponsor
Sanofi